Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
TopWeightLoss.ioTreatmentsHub

Medvi vs trimrx vs SHED: The Support-Tier Showdown

Last updated: Aug 16, 2026

We may earn a commission when you visit providers through links on this page - it never affects our rankings (how we stay objective). This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

Here’s the short version

At $179-$199 a month, these three sell more than medication - each wraps the same compounded GLP-1s in a different support philosophy. Medvi bundles video visits, a dietician and care coaching behind a 14,372-review Trustpilot record. trimrx sells flexibility: no contract, optional discounts, clinical guidance. SHED sells accountability: formal health coaching plus the market's only lose-5%-in-120-days-or-your-money-back guarantee.

Medvi logo
14,372 reviews onTrustpilot

Summer Sale! up to $100 off

Visit Medvi
trimrx logo
5,497 reviews onTrustpilot

Limited time offer - $140 off all weight loss plans

Visit trimrx
SHED logo
1,120 reviews onTrustpilot

Get 30% off your first month

Visit SHED

Medvi vs trimrx vs SHED: side by side

Real published prices and terms - the differences that actually decide this matchup.

MedvitrimrxSHED
Semaglutide$179/mo, all-inclusive$179/mo (reg. $299)$199/mo (20% off first month)
Tirzepatide$249/mo, all-inclusive$259/mo$299/mo (20% off first month)
Billing & commitmentMonthly, all-inclusive - no surprise charges; HSA/FSA approvedMonthly - no long-term contract; multi-month discountsMonthly; HSA/FSA approved
ShippingFree shippingFree home deliveryFree home delivery
SupportVideo visits + free dietician & care coachingLicensed clinical guidance through dose changesProvider visit + health coaching included
Guarantee / refund--Lose 5% of body weight in 120 days or your money back
Standout4.4 on Trustpilot across 14,372 reviewsFlexibility-first: month-to-month always availableThe market's firmest results guarantee

Our verdict

Match the model to your failure mode. If past attempts failed for lack of guidance, Medvi's high-touch care - with the receipts to prove it works - is the pick. If you want premium care without being locked to anything, trimrx. If you need stakes and structure to follow through, SHED's guarantee literally pays you back if the program doesn't deliver. Price separates them by only $20; the support philosophy is the real choice.

Medvi vs trimrx vs SHED: FAQs

Is Medvi, trimrx or SHED better for support?

They support differently: Medvi includes video visits with providers plus a free dietician and care coaching (rated 4.4 across 14,372 Trustpilot reviews); SHED includes formal health coaching backed by a money-back guarantee; trimrx includes clinical guidance through dose changes with a flexibility-first, no-contract model.

Which has a money-back guarantee?

SHED - lose 5% of your body weight in 120 days or your money back, conditioned on following the program (terms on its site). Medvi and trimrx don't advertise results guarantees.

Are these worth it over cheaper GLP-1 providers?

The active ingredients are the same as the $59-$99 budget tier - the premium buys the support layer. If coaching, accountability or a personal provider relationship is what determines whether you stick with treatment, the tier can pay for itself; if you're self-directed, the budget tier delivers the same medication for less.

Break it down two at a time

The head-to-head comparisons between these providers.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)